JP2022536408A5 - - Google Patents

Info

Publication number
JP2022536408A5
JP2022536408A5 JP2022515975A JP2022515975A JP2022536408A5 JP 2022536408 A5 JP2022536408 A5 JP 2022536408A5 JP 2022515975 A JP2022515975 A JP 2022515975A JP 2022515975 A JP2022515975 A JP 2022515975A JP 2022536408 A5 JP2022536408 A5 JP 2022536408A5
Authority
JP
Japan
Application number
JP2022515975A
Other languages
Japanese (ja)
Other versions
JPWO2020237172A5 (https=
JP2022536408A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034273 external-priority patent/WO2020237172A1/en
Publication of JP2022536408A publication Critical patent/JP2022536408A/ja
Publication of JP2022536408A5 publication Critical patent/JP2022536408A5/ja
Publication of JPWO2020237172A5 publication Critical patent/JPWO2020237172A5/ja
Priority to JP2025034659A priority Critical patent/JP2025093991A/ja
Pending legal-status Critical Current

Links

JP2022515975A 2019-05-23 2020-05-22 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法 Pending JP2022536408A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025034659A JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962852000P 2019-05-23 2019-05-23
US62/852,000 2019-05-23
PCT/US2020/034273 WO2020237172A1 (en) 2019-05-23 2020-05-22 Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025034659A Division JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2022536408A JP2022536408A (ja) 2022-08-15
JP2022536408A5 true JP2022536408A5 (https=) 2023-05-08
JPWO2020237172A5 JPWO2020237172A5 (https=) 2023-05-08

Family

ID=73458156

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022515975A Pending JP2022536408A (ja) 2019-05-23 2020-05-22 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法
JP2025034659A Pending JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025034659A Pending JP2025093991A (ja) 2019-05-23 2025-03-05 アルコール誘発性皮膚紅潮の治療および緩和のための組成物および方法

Country Status (7)

Country Link
US (1) US20220226286A1 (https=)
EP (1) EP3973030A4 (https=)
JP (2) JP2022536408A (https=)
KR (1) KR20220012903A (https=)
CN (2) CN119909065A (https=)
TW (1) TW202110437A (https=)
WO (1) WO2020237172A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102879756B1 (ko) 2022-11-11 2025-11-12 대한민국 이상지질혈증 예측 또는 진단용 snp 마커 및 이의 용도
KR102893400B1 (ko) 2022-11-21 2025-12-02 대한민국 당뇨병 예측 또는 진단용 hectd4 snp 마커 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468319A (en) * 1987-09-09 1989-03-14 Nonogawa Shoji Yk Anti-inflammatory
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
TW271400B (https=) * 1992-07-30 1996-03-01 Pfizer
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
US20110053999A1 (en) * 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
CN101232822B (zh) * 2005-07-29 2012-11-14 蒂马基金会 用于减缓乙醇代谢和用于降低乙醇诱导的疾病风险的组合物
KR20090117950A (ko) * 2007-03-08 2009-11-16 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절자 및 그것의 사용 방법
JP2011051942A (ja) * 2009-09-03 2011-03-17 Glovia:Kk 認知症治療薬
JPWO2011043365A1 (ja) * 2009-10-07 2013-03-04 学校法人武庫川学院 遺伝子型判定方法
EP2467136B1 (en) * 2009-12-07 2014-05-07 Raptor Therapeutics Inc. 4-methylpyrazole formulations
MX2013002162A (es) * 2010-08-24 2013-04-05 Univ California Metodos para tratar la intoxicacion con alcohol, transtornos debido al consumo de alcohol y alcolismo que comprenden la administracion de dihidromiricetina.
FI128082B (en) * 2014-09-15 2019-09-13 Biohit Oyj Preparations for the treatment and prevention of alcohol redness and alcohol-induced hypersensitivity reactions
EP3323412A1 (en) * 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole

Similar Documents

Publication Publication Date Title
CN305805443S (https=)
CN305857630S (https=)
CN305536623S (https=)
CN305539862S (https=)
CN305541126S (https=)
CN305542213S (https=)
CN305578967S (https=)
CN305580511S (https=)
CN305603408S (https=)
CN305611095S (https=)
CN305532572S (https=)
CN305615849S (https=)
CN305649225S (https=)
CN305652203S (https=)
CN305653247S (https=)
CN305656029S (https=)
CN305665517S (https=)
CN305695642S (https=)
CN305696364S (https=)
CN305696499S (https=)
CN305697752S (https=)
CN305698061S (https=)
CN305703361S (https=)
CN305715455S (https=)
CN305718513S (https=)